Sfoglia per Autore "Kapsoritaki, A. I."
Items 1-3 di 3
-
Angiogenin, Angiopoietin-1, Angiopoietin-2, and Endostatin Serum Levels in Inflammatory Bowel Disease
Oikonomou, K. A.; Kapsoritakis, A. N.; Kapsoritaki, A. I.; Manolakis, A. C.; Tiaka, E. K.; Tsiopoulos, F. D.; Tsiompanidis, I. A.; Potamianos, S. P. (2011)Background: Angiogenesis is a complex process, involving a great number of mediators. It is implicated in the pathogenesis of numerous diseases, holding a critical role in inflammatory bowel disease (IBD). The objective ... -
Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?
Oikonomou, K. A.; Kapsoritakis, A. N.; Kapsoritaki, A. I.; Manolakis, A. C.; Tsiopoulos, F. D.; Germenis, A. E.; Potamianos, S. P. (2010)Background: Epidermal growth factor (EGF) is a multipotent peptide which contributes to epithelial development, inhibition of gastric acid secretion, acceleration of wound healing, and promotion of angiogenesis. The aim ... -
Imbalance of tissue inhibitors of metalloproteinases (TIMP)-1 and-4 serum levels, in patients with inflammatory bowel disease
Kapsoritakis, A. N.; Kapsoritaki, A. I.; Davidi, I. P.; Lotis, V. D.; Manolakis, A. C.; Mylonis, P. I.; Theodoridou, A. T.; Germenis, A. E.; Potamianos, S. P. (2008)Background: Tissue inhibitors of metalloproteinases (TIMPs) play a key role in tissue degradation and remodeling. Since chronic inflammation is associated with tissue remodeling in inflammatory bowel disease (IBD), we ...